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The pale ear (ep) mouse strain is a model for the Hermansky–Pudlak syndrome type 1 (HPS-1), an autosomal
recessive disorder causing pigmentary dilution, visual disturbances, bleeding diatheses, pulmonary fibrosis,
and granulomatous colitis. The ep mice have a coat color very similar to the black-colored parental strain,
C57BL/6. However, the ears and tails of ep mice are significantly hypopigmented compared with the control
animals, suggesting that the gene mutation in ep mice reveals a differential regulation of melanocyte function in
dorsal back skin melanocytes versus tail or ear skin. In this study, we analyzed the mutant phenotype in detail
and determined that in the tail, the defective gene causes delayed onset of interfollicular epidermal melanocyte
tyrosinase activity, decreased numbers of melanocytes in the interfollicular epidermis and dermis, and severe
immaturity of tail epidermal melanosomes, findings not observed in dorsal back follicular melanocytes. These
results highlight differences between follicular and interfollicular melanocyte biology and demonstrate that
defects in the ep protein not only affect melanosome biogenesis, but also play a developmental role in
determining interfollicular epidermal and dermal melanocyte function. The implications of these findings for
the mechanisms governing physiologic variation in human pigmentation and for the pathogenesis of vitiligo are
discussed.
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INTRODUCTION
Hermansky–Pudlak syndrome (HPS) is an autosomal disorder
described in humans and mice (Wei, 2006). There are eight
known human HPS genes causing different subtypes of HPS
(HPS-1 to -8), and at least 14 murine HPS genes, eight of
which are orthologous to the human genes. Mutations in two
HPS genes, HPS1, and HPS4, (murine orthologs are pale ear
(ep) and light ear (le), respectively), cause the most common
and most severe clinical subtypes, in which affected
individuals have oculocutaneous albinism, prolonged bleed-
ing, and can suffer morbidity from granulomatous colitis and
premature mortality from pulmonary fibrosis. Similarly, the
corresponding mouse models ep and le mice are phenotypic
mimics and are indistinguishable from one another, both
having dorsal coat colors similar to parental C57BL/6 color,
but having markedly hypopigmented ears and tails. The two
strains also have comparable levels of decreased bleeding
time, kidney lysosomal enzyme secretion, concentration of
platelet serotonin, and the same magnitude of increased
thrombin-stimulated platelet lysosomal enzyme secretion
compared with the parental C57BL/6 strain (Swank et al.,
1998).
The similarity in phenotypes between HPS-1 and HPS-4
subtypes and between ep and le mice is explained by the
finding that intracellular HPS1 and HPS4 proteins associate
together in a protein complex termed biogenesis of lysosome-
related organelle complex BLOC-3 (Chiang et al., 2003;
Martina et al., 2003; Nazarian et al., 2003), as do the ep and
le proteins (Chiang et al., 2003). In the absence of ep protein,
le is degraded and conversely, in the absence of le, ep is
degraded, thus a lack of either BLOC-3 component inacti-
vates the other component as well (Chiang et al., 2003).
Previous work by this laboratory examined dorsal back
follicular melanocytes from HPS mice and results suggested
that the BLOC-3 complex functions early in melanosome
biogenesis (Nguyen et al., 2002). We reported that mutations
in HPS1/ep and HPS4/le genes introduced a rate-limiting step
before the formation of stage II melanosomes (which are
elliptical and striated) from stage I melanosomes (which are
unpigmented and contain intralumenal vesicles), because
there was a slight increase in the proportion of immature
melanosomes. Despite this rate-limiting step, the majority of
melanosomes in both ep and le dorsal back follicular
melanocytes were stage IV melanosomes, similar to the
predominantly stage IV melanosomes found in the parental
wild-type mouse strain C57BL/6 cells, a result reflected in the
near normal coat color of ep and le mice.
Our previous analysis did not address the marked
hypopigmentation observed in ep and le tail and ears. This
phenotype is unique among the HPS mouse models, in that
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the other HPS strains have pigment dilution of the ears, tails,
and dorsal back coat hair. The ep/le phenotype suggested to
us that the ep and le mutations unmask a mechanism of
differential regulation of melanocytes in the tail and ear
versus in dorsal back skin. One key difference between dorsal
back skin and tail/ear skin in mice is that melanocytes only
reside in follicles on the adult mouse back skin, whereas
melanocytes are found in the interfollicular epidermis and
dermis as well as follicles of tail and ear skin (Fitch et al.,
2003). So it is possible that regulation of melanocytes differs
in follicles versus interfollicular skin or that melanocytes in
different anatomic units (e.g., back vs tail) are differentially
regulated, or perhaps both levels of differential regulation
exist. A precedent in the skin for both regulation at the
follicular versus non-follicular level and at the level of the
anatomic unit exists for keratinocytes. For example, keratin
expression differs between follicular and interfollicular
keratinocytes, and in different specialized anatomic units
such as the palms and soles, compared with other sites
(Knapp et al., 1986; Moll et al., 1987; Michel et al., 1996).
Thus, the ep/le phenotype suggests that the ep and le genes
have a greater role in regulating interfollicular epidermal and
dermal melanocytes versus follicular melanocytes and may
also play a role in regulating melanocytes in specialized
anatomic units such as the ear and tail.
In this study, we analyzed the ep phenotype in detail to
determine in tail tissue at what level the defect in melanocyte
regulation exists. Previous genetic analyses indicate that
skin melanocyte function can be regulated at the level of
(a) migration from the neural crest to the skin, (b) expression
and function of melanocyte-specific proteins, and (c) melano-
some formation (Tomita and Suzuki, 2004). We found that
defective ep protein function caused delayed onset of
interfollicular epidermal melanocyte tyrosinase activity,
decreased numbers of interfollicular melanocytes in the
epidermis and dermis and severe immaturity of tail inter-
follicular epidermal melanosomes, effects not seen in dorsal
back follicular melanocytes.
RESULTS
Interfollicular epidermal and dermal melanocyte defects in tails
of le and ep mice
The tails, ears, and paws of adult ep and le mice are
hypopigmented compared with control heterozygous litter-
mates, with tails more markedly affected than the ears
(Figure 1). The paws are subtly hypopigmented, and the
dorsal back fur is not discernibly affected. When tail tissue
was examined by light microscopy after dihydroxyphenyl-
alanine (DOPA) staining, (Figure 2b), it was seen that the
level of melanization is significantly decreased in ep tail
epidermis and dermis. Incidentally, it was observed that the
size of epidermal melanocytes was markedly smaller than
melanocytes residing in the dermis in the control tissue
(Figure 2b). In the mutant dermis, a near absence of
melanocyte staining was noted (Figure 2b and d). Quantita-
tion of the number of stained melanocytes showed a decrease
in epidermal melanocytes as well (Figure 2b and c). Similar
results were seen in le tail tissue (data not shown). This
finding suggested to us that the HPS1/ep and HPS4/le genes
may influence the function of melanocytes developmentally.
Onset of pigmentation was developmentally delayed in ep mice
The next studies sought to establish whether defective le and
ep genes caused a delay in melanocyte-specific protein
expression, a disruption in melanocyte arrival into the skin
from the neural crest or survival and proliferation once in the
skin. The following analyses focus on ep mice for clarity, but
similar results were observed for le as well (data not shown).
Interfollicular but not follicular melanocytes were analyzed,
as an examination of the tissue by light microscopy revealed
that the melanocyte differences were minimal in the follicle
and it was technically difficult to quantitate in that densely
pigmented cellular compartment. No qualitative differences
were noted between ep and control follicles (data not shown).
Comparison of neonatal pups from ep homozygous (ep/ep)
versus heterozygous littermates (ep/þ ) from post-gestational
day 1 to 9 (P1–P9) showed a delay in the pigmentation over
the head, body, and limbs of ep pups (Figure 3), as noted
earlier by others (Lane and Green, 1967). Hypopigmentation
persisted in the ears, tail, and paws, but by P9 elsewhere the
pigment approached the color of the heterozygote litter-
mates. This result suggested that the HPS1 defect might cause
a developmental defect in melanocyte function, causing
delayed pigmentation over the back and causing persistent
hypopigmentation of the tails, ears, and paws.
Delayed onset of tyrosinase activity and decreased numbers of
melanocytes in ep tail
Next, skin tissue from neonatal tail and back skin was
examined by light microscopy to determine if any differences
were apparent in melanocyte number, activity and/or
distribution. Tyrosinase activity was detected using DOPA
staining on skin tissue harvested from neonatal mice ages
post-gestational days P1–P9. In ep, no epidermal DOPA
staining was detectable in P1 tissue in contrast to positive
staining seen in heterozygous littermates (Figure 4a and b);
positive staining for ep is only detected at P4. In addition, the
number of melanocytes detected appeared to decrease in the
le/+ le/le ep/+ ep/ep
Figure 1. ep and le mice have hypopigmented ears, tails and paws. Control le
heterozygote (le/þ ), le homozygous mutant (le/le), control ep heterozygote
(ep/þ ), ep homozygous mutant (ep/ep). Eight-week-old littermates are shown.
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epidermis at a more rapid rate compared with in the
heterozygote tissue after peaking at P4 (Figure 4b). In the
dermis, tissue showed staining at P1 in two different patterns.
There were dendritic melanocytes arrayed in a reticular
pattern (Figure 5a, ep/þ , P1), corresponding to dermal
interfollicular melanocytes, and then there was also a
repeating pattern of aggregates of pigment (Figure 5a,
ep/ep, P1, arrow), corresponding to developing hair bulbs.
(These hair bulbs are also present in ep/þ at P1 but are not
apparent in the figure because they are out of the plane of
focus.) The ep mutant lacked detectable reticular interfolli-
cular pigmentation until P4 and then it was detected at a
reduced staining intensity. At all time points, the number of
detectable tyrosinase-positive melanocytes was decreased in
ep/ep compared with in ep/þ heterozygotes (Figure 5b).
These data suggest that the tail remains hypopigmented in
part owing to the delayed onset of tyrosinase activity (seen
in the epidermis), the decreased numbers of pigmenting
melanocytes (in the dermis) and the rapid loss of pigmenting
melanocytes from the epidermis after a peak in numbers
at P4.
Markedly impaired melanosome formation in tail interfollicular
epidermis
Our previous studies demonstrated that the process of
melanosome biogenesis in dorsal back skin follicular
melanocytes in ep and le 4-week-old mice was only slightly
impaired compared with in control C57BL/6 mice (Nguyen
et al., 2002). In both mutant and control melanocytes, stage
IV melanosomes were made in significant amounts, leading
to the near black coat color in the mutants. However,
quantitation of the proportions of melanosomes seen in
back follicular melanocytes demonstrated a slightly reduced
proportion of intracellular steady state stage IV melanosomes
with a concomitant increase in the proportion of immature
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Figure 2. Decreased tyrosinase activity in tail epidermis and dermis of 4-week-old ep mutants. Tail tissue from 4-week-old mutant and heterozygote littermates
were stained with DOPA to detect tyrosinase activity and whole-mount tissue sections were examined by light microscopy. ep/þ , wild-type heterozygote
littermate; ep/ep, ep mutant littermate. (a) Control tail epidermis, (C57BL/6). Note organization of melanocytes into ‘‘clusters’’ surrounded by areas relatively
sparsely populated by melanocytes. Bar¼100 mm. Brown pigment surrounding black melanocytes is due to melanocytes out of the plane of focus. (b) Tail
epidermis examined by light microscopy, comparing ep/þ with ep/ep. Bar¼ 100 mm. Arrows, hair follicles out of plane of focus. Representative interfollicular
melanocytes are boxed. (c) Number of melanocytes detected in ep/ep versus ep/þ tail epidermis at original magnification 20. Five fields, each field focusing
on a melanocyte ‘‘cluster’’, were counted and averaged. (d) Number of melanocytes detected in ep/ep versus ep/þ tail dermis.
P1 P4 P6 P9
Figure 3. Developmental delay in onset of pigmentation in ep mice.
Postgestational day 1–9 (P1–P9) pups shown. For each pair, wild-type ep/þ
heterozygote is on the left; mutant ep/ep littermate is on the right. Note that
although dorsal back fur pigment gradually darkens to almost wild-type hue,
tail, ears, and paws remain hypopigmented.
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Figure 4. Delayed onset of tyrosinase activity in neonatal ep tail interfollicular epidermis. Tail tissue was harvested from post-gestational day 1 (P1) through
post-gestational day 9 (P9) mice, epidermis and dermis separated and stained with DOPA and whole-mount tissue sections examined by light microscopy.
(a) ep/þ , wild-type heterozygote; ep/ep, mutant homozygous ep. Arrows, hair follicles out of plane of focus. Representative interfollicular melanocytes are
boxed. Original magnification  20. (b) Delayed onset of tyrosinase activity and rapid decrease in the number of melanocytes in ep/ep tail neonatal epidermis.
P1, Po0.0001; P4, P¼ 0.8; P6, P¼ 0.03; P9, Po0.001.
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Figure 5. Decreased numbers of melanocytes in neonatal ep interfollicular tail dermis. (a) Tail tissue was harvested and treated as in Figure 4. (a) ep/þ , wild-
type heterozygote; note reticular pattern of interfollicular melanocytes; follicular melanocytes are out of the plane of focus. ep/ep, mutant ep; P1, note absence
of reticularly arrayed melanocytes, only follicular melanocytes are visible. Arrows, hair bulbs. Representative interfollicular melanocytes are boxed. Original
magnification  20. (b) Decreased numbers of melanocytes in the dermis of ep/ep neonatal tail. P1, Po0.0001; P4, P¼0.01; P6, Po0.01; P9, Po0.01.
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melanosomes in mutant melanocytes. This suggested that a
rate-limiting step (rather than a block) was introduced into the
pathway of melanosome biogenesis in the mutant cells.
In contrast, in the present study, it was observed that
melanosomes in 4-week-old ep/ep tail interfollicular epi-
dermis were markedly more immature than melanosomes in
control tissue (Figure 6a). Notably, there are very few stage IV
fully pigmented elliptical melanosomes. Most of the ep/ep
melanosomes are small, spherical, and few are striated. This
is in contrast to both control tail tissue (Figure 6a) and
to mutant ep/ep dorsal back tissue (Nguyen et al., 2002), in
which numerous stage IV melanosomes were evident
in follicular melanocytes. Quantitation of the percentage
of different types of melanosomal forms observed in control
versus mutant tail epidermal melanocytes demonstrated that
only 23% of melanosomes are stage IV in ep/ep tail
epidermis, and the majority of the melanosomes are
immature or aberrant forms, whereas in the control animals,
85% of melanosomes are stage IV (Figure 6b).
At least two possibilities could account for the increased
percentage of immature melanosomes in ep melanocytes.
Melanosome biogenesis could be impaired, as suggested by
the numerous aberrant melanosomal forms observed, or
perhaps there is an increased rate of secretion of mature
melanosomes. To distinguish between these possibilities, the
number of melanosomes/unit area was quantitated for ep and
control melanocytes (Figure 6c), and found not to differ
significantly; in fact, the number of melanosomes/unit area
seems to be slightly increased in ep compared with in the
control. Thus preferential secretion of mature forms does not
account for the predominance of immature melanosomal
forms.
Next, to further determine the extent of melanosome
biogenesis impairment, the average size of type IV fully
pigmented melanosomes was compared in ep to control cells
(Figure 6d). The size of melanosomes in ep was significantly
decreased. Thus, a significant degree of impairment of
melanosome biogenesis also contributed to the marked
degree of hypopigmentation in the tail.
Dramatically reduced numbers of melanocytes in neonatal
ep/ep back interfollicular epidermis and dermis
Neonatal back skin was examined to determine the basis for
the delayed onset of pigmentation observed over the back
(Figure 3). DOPA stained back epidermis showed a striking
lack of interfollicular melanocytes at all time points examined
(Figure 7a and b). The dermis showed a similar lack of
melanocyte staining at P1 (Figure 8a and b). Examination of
later time points in the dermis was hampered technically by
the density of hair follicles, which obscured the viewing of
interfollicular melanocytes. Thus, the delayed pigmentation
over the backs of ep pups is due to the lack of epidermal
100
80
60
40
20
0
C57BL/6 Pale ear
Mouse strain
C57BL/6 Pale ear
Mouse strain
C57BL/6 Pale ear
Mouse strain
% undefined types
% type I melanosomes
% type II/III melanosomes
% type IV melanosomes
Pe
rc
e
n
t o
f t
ot
al
 
m
e
la
no
so
m
es
25
20
15
10
5
0M
el
an
os
om
es
 
 
 
 
/u
ni
t a
re
a
0.6
0.5
0.4
0.3
0.2
0.1
0
Av
e
ra
ge
 m
el
an
os
om
e
di
am
et
er
 (m
icr
on
s)
Melanosomes/unit area
Melanosome size
P = 0.4
P<<0.0001
a
b c
d
2
7
30
85
11
36
27
C57BL /6 ep/ep
Figure 6. Biogenesis of melanosomes in ep tail interfollicular epidermis is markedly impaired. (a) Transmission electron microscopy of tail epidermis. Stage I
melanosomes have intraluminal vesicles (middle inset). Stage II melanosomes have intralumenal striations, (left inset). Stage III have evidence of pigment
deposition and stage IV have pigment filling the lumen, obscuring intralumenal contents. Aberrant appearing undefined melanosomal types are vesicles similar
in size to melanosomes with granular internal content, without discernable intralumenal vesicles, striations, or pigment (right inset). Nuc, melanocyte nucleus;
Ker, neighboring keratinocyte. Bar¼ 0.5mm. (b) Percentages of stage I–IV melanosomes in ep homozygotes and controls. (c) Number of melanosomes/unit area.
(d) Average size of fully pigmented stage IV melanosomes.
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pigmentation. The onset of hair growth and the appearance of
relatively normally pigmented hair accounts for the later
appearance of ‘‘normal’’ pigmentation owing to the relatively
unimpaired function of follicular melanocytes.
DISCUSSION
In this study we have investigated the basis for the persistent
tail hypopigmentation and delayed onset of pigmentation
observed over the back of the HPS ep mouse strain. Tail
hypopigmentation is due to a combination of decreased
numbers of melanocytes arriving or surviving in the
epidermis and dermis, together with a delay in onset of
tyrosinase activity in epidermal melanocytes, and a severe
inhibition of melanosome maturation. The delay in back
pigmentation was owing to a dramatically decreased number
of interfollicular melanocytes in both the epidermis and
dermis.
In mice, the color phenotype of tail, ears, and paws is
mainly determined by epidermal (i.e., interfollicular) melano-
cytes, whereas the back color is determined by coat color,
produced by follicular melanocytes. The observation that the
coat color of ep is comparable to the parental C57BL/6 strain,
yet the skin of the tail, ears, and paws are hypopigmented
suggests that mutations in the HPS1/ep gene predominantly
affect the phenotype of interfollicular melanocytes, with a
negligible effect on follicular melanocytes. Indeed, in this
study, the HPS1/ep gene was demonstrated to exert a
differential regulation of melanosome biogenesis in a niche-
specific manner: melanosome biogenesis was found here to
be more markedly blocked in tail epidermal melanocytes
compared with what was previously observed in back skin
follicular melanocytes (Nguyen et al., 2002).
This differential regulation by HPS1/ep of melanocytes in
different locations may explain why previous reports found
significant abnormalities in melanosomes in the retinal pig-
ment epithelium and choroidal melanocytes (Gardner et al.,
1997), whereas we reported that defects in melanosomes in
follicular melanoctyes were minimal (Nguyen et al., 2002),
but are now reporting significant defects in melanosomes
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Figure 7. Marked decrease in tyrosinase activity in back neonatal interfollicular epidermis. Back skin tissue was harvested and treated as described in Figure 4.
(a) Whole-tissue mount of epidermis examined by light microscopy. Representative interfollicular melanocytes boxed. Follicles can be seen as objects out of the
plane of focus, arrows. ep/þ , wild-type heterozygote; ep/ep, mutant ep. Original magnification  20. (b) Numbers of interfollicular melanocytes in back
neonatal epidermis. P1-P9, Po0.001.
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Figure 8. Significant decrease in tyrosinase activity in ep back neonatal
dermis at P1. Back skin tissue was harvested and treated as described in
Figure 4. (a) Whole-tissue mount of dermis examined by light microscopy.
ep/þ , wild-type heterozygote; ep/ep, mutant ep. Arrows, hair follicles out
of plane of focus. Representative interfollicular melanocyte is boxed.
Original magnification  20. (b) Numbers of interfollicular melanocytes
in back neonatal dermis.
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from interfollicular melanocytes. Interestingly, the defects in
the ep retinal pigment epithelium and choroidal melanocytes
lead to increased size of melanosomes, whereas in ep
epidermal melanocytes, the melanosomes are significantly
smaller than those in control cells.
Owing to the differential effects of mutations in HPS1/ep on
follicular versus interfollicular melanocytes, defects would be
predicted to cause a more pronounced pigmentary defect in
humans, who have more of their overall pigment phenotype
determined by interfollicular melanocytes compared to mice,
whose pigment phenotype is determined primarily by
follicular melanocytes. Conversely, it has been noted that
many of the HPS mouse strains (pallid, sandy, and cappucci-
no) whose gene products associate together in the multi-
subunit BLOC-1 exhibit striking hypopigmentation but the few
humans with BLOC-1 defects are only moderately hypopig-
mented (Wei, 2006). This could be because in contrast to the
mutations affecting the BLOC-3 subunit ep, the BLOC-1
mutations may affect the follicular melanocytes predomi-
nantly, and the interfollicular melanocytes to a lesser extent.
The findings reported here may have implications regarding
mechanisms underlying the physiological variations observed
in human pigmentation. For example, the degree of physio-
logical pigmentation of human hair, skin, and eyes do not
necessarily correlate. Thus, persons with black hair can have
fair skin. This disassociation of pigment phenotype could be
explained in part by genes that regulate follicular melanocytes
differentially from interfollicular melanocytes, as is observed
here for HPS1/ep. Thus, non-pathogenic polymorphisms in
HPS1/ep (Bailin et al., 1997) may contribute to the varied
physiological pigmentation observed in humans.
These findings lead to an interesting question concerning
the expression of the ep gene. In the literature, it has been
reported as being ubiquitously expressed (Oh et al., 1996;
Gardner et al., 1997). However, there may be fine specificity
within certain tissues such as skin. For example, although the
melanogenic enzymes tyrosinase and TRP1 are expressed in
follicular bulb melanocytes, they are not expressed in the
follicular outer root sheath melanocytes (Horikawa et al.,
1996). There may likewise be differential expression of ep in
interfollicular versus follicular skin.
The results of this present study are intriguing in light of
disease processes of melanocytes that affect interfollicular
and follicular melanocytes differentially, such as vitiligo.
Vitiligo is thought to be an autoimmune disorder, but the
etiology remains undetermined. In vitiligo, pigmented epi-
dermal melanocytes disappear from localized patches on the
skin, and repigmentation occurs in a folliculocentric manner,
that is, melanization begins perifollicularly and spreads
circumferentially outwards. This has led to the hypothesis
that follicular melanocyte stem cells are spared the vitiligi-
nous process, whereas epidermal melanocytes are not. It is
interesting to speculate on the role of genes that differentially
regulate follicular versus interfollicular melanocytes in the
pathophysiology of vitiligo. For example, it is possible that
the gene products (or peptides derived from the intracellular
gene products) of ep are targets for the autoimmune
inflammatory process.
Our findings of decreased melanocyte numbers in the
epidermis and dermis and delayed onset of melanocyte
protein function suggests that mutations in HPS1/ep gene
influence melanocyte development. In this study, it was not
determined if the delay in tyrosinase activity was owing to a
delay in melanocyte arrival in the skin because of impaired
migration of melanoblasts from the neural crest, owing to
decreased survival or proliferation once melanocytes have
arrived in the skin, or owing to downregulation of melano-
genic genes such as tyrosinase in a subpopulation of
melanocytes, leading to the detection of fewer cells by
DOPA staining. How would one or more of these processes
be impaired in ep cells? Melanocytes with defective HPS1
have aberrant trafficking of melanosomally targeted proteins
(Richmond et al., 2005). It is possible that these mistargeted
proteins are trafficked to the plasma membrane or that
proteins normally targeted to the plasma membrane are
mistakenly targeted to intracellular organelles such as the
lysosome, disrupting the normal cell–cell interactions, or
chemotactic detection required by migrating melanocytes.
Alterations in the cell surface molecules could also affect
cell-signaling cascades and disrupt both proliferation and
survival. Additionally, impaired migration or proliferation
could result from alterations in the actin cytoskeleton, as it
has been suggested that cells from HPS mice have abnormal
actin organization (Chiang et al., 2005). Further studies are
needed to definitively distinguish between the above
possibilities, which are not necessarily mutually exclusive.
It will also be of interest to determine if HPS1 influences the
development of other organs and systems affected by HPS,
that is, lungs, eyes, colon, and platelets.
In summary, defects in the HPS1/ep protein have
unmasked a differential regulatory role for the protein in
follicular versus interfollicular melanocytes, cause decreased
numbers of melanocytes to be detected developmentally in
the epidermis and dermis, and a significant block in
melanosome biogenesis in epidermal but not follicular
melanocytes. This is the first demonstration to our knowledge
for a role for an HPS gene in influencing the developmental
fate of melanocytes.
MATERIALS AND METHODS
Mice
Tissue from ep homozygous mutant mice was compared to tissue
from heterozygous littermates (which had pigment phenotypes
similar to the parental C57BL/6 parental strain). Tails were treated
with the depilatory agent Nair lotion (Church & Dwight, Princeton,
NJ) for 9–10 minutes, wiped clean then rinsed with water, and dried.
Tail skin was harvested from mice after decapitation. Mice were
maintained in an American Association for the Accreditation of
Laboratory Animal Care accredited facility and all protocols were
approved by the San Francisco VA Institutional Animal Care and Use
Committee.
DOPA staining
Tail skin was isolated and placed into 2 M NaBr for 2–4 hours at room
temperature. The epidermis and dermis were separated and washed
twice in 0.1 M phosphate buffer pH 6.8. The tissue was then
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incubated at 371C for 2 hours in DOPA solution (0.5 mg 3,4-
dihydroxy-L-phenylalanine (Sigma, St Louis, MO) per ml 0.1 M
phosphate buffer pH 6.8). The tail skin was then washed twice with
phosphate-buffered saline and fixed for 15–60 minutes in 4%
paraformaldehyde (Sigma) at room temperature. The tissue was
stored at 41C in phosphate-buffered saline/10% glycerol (Fisher
Scientific, Fair Lawn, NJ) and mounted in the same solution for
examination by light microscopy.
Electron microscopy
Tail skin was harvested and placed into modified Karnovsky’s
fixative (0.1 M cacodylate/2% paraformaldehyde/2% gluteraldehyde/
0.06% calcium). The tissue was then washed and stained with
reduced osmium (1.5% potassium ferrocyaninde/2% osmium tetra-
oxide) for 2 hours then washed with water and dehydrated in
increasing concentrations of ethanol, then propylene oxide. The
samples were then embedded in epon, sectioned, and stained with
10% uranyl acetate/50% methanol. Quantitation of percentages of
melanosomes was performed as previously reported (Nguyen et al.,
2002). More than 50 melanosomes were analyzed per strain, two
animals/strain were surveyed.
Statistics
P-values were calculated using the Student t-test, using two-tailed
distribution, and two-sample unequal variance.
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